I+D de fármacos
GI-1606
![Foto de Abel](/img/nophoto.png)
Abel
Crespo Gavilán
Publicacións nas que colabora con Abel Crespo Gavilán (8)
2021
-
3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition
Journal of medicinal chemistry, Vol. 64, Núm. 1, pp. 458-480
2017
-
3-Oxopyridazin-5-yl-Chalcone Hybrids: Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation
ChemistrySelect, Vol. 2, Núm. 17, pp. 4920-4933
2013
-
Discovery of 3,4-dihydropyrimidin-2(1 H)-ones as a novel class of potent and selective A2B adenosine receptor antagonists
ACS Medicinal Chemistry Letters, Vol. 4, Núm. 11, pp. 1031-1036
-
Three-component assembly of structurally diverse 2-aminopyrimidine-5- carbonitriles
ACS Combinatorial Science, Vol. 15, Núm. 7, pp. 370-378
2011
-
Convergent assembly of structurally diverse quinazolines
Organic and Biomolecular Chemistry, Vol. 9, Núm. 2, pp. 351-357
-
Supported TBD-assisted solution phase diversification of formyl-aza-heterocycles through alkylation-knoevenagel one pot sequences
Combinatorial Chemistry and High Throughput Screening, Vol. 14, Núm. 7, pp. 570-582
2008
-
Synthetic applications of polystyrene-supported 1,1,3,3- tetramethylguanidine
Combinatorial Chemistry and High Throughput Screening, Vol. 11, Núm. 10, pp. 843-847
2006
-
Pyridazines part 41: Synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl) pyridazin-3(2H)-ones
Bioorganic and Medicinal Chemistry Letters, Vol. 16, Núm. 4, pp. 1080-1083